Gossamer Bio financials
$11.58+0.52%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.2M | $17.0M | $13.8M | $13.3M | $11.5M | $9.9M | $9.4M | $9.5M | $95.8M | $0.00 | $0.00 | $0.00 |
| Gross profit | $9.2M | $17.0M | $13.8M | $13.3M | $11.5M | $9.9M | $9.4M | $9.5M | $95.8M | $0.00 | $0.00 | $0.00 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — | — | — |
| Operating income | -$26.1M | -$44.9M | -$46.0M | -$49.1M | -$38.8M | -$36.8M | -$36.1M | -$33.9M | $52.1M | -$42.0M | -$49.0M | -$40.5M |
| Net income | $16.9M | -$46.7M | -$47.2M | -$48.2M | -$38.3M | -$36.6M | -$33.0M | -$30.8M | $49.2M | -$41.9M | -$48.1M | -$40.0M |
| Net margin | 182.9% | −275.2% | −342.3% | −362.7% | −333.1% | −370.5% | −352.2% | −324.9% | 51.4% | — | — | — |
| Diluted EPS | $-6.40 | $-16.00 | $-16.29 | $-16.80 | $-13.60 | $-12.80 | $-12.33 | $-11.20 | $17.60 | $-15.20 | $-16.95 | $-16.80 |
| EBITDA | -$26.1M | -$44.9M | -$52.3M | -$49.1M | -$38.8M | -$36.8M | -$45.8M | -$33.7M | $52.0M | -$41.4M | -$49.0M | -$40.1M |
| Operating cash flow | -$39.4M | -$38.7M | -$48.3M | -$36.2M | -$47.1M | -$39.7M | -$35.5M | -$32.0M | $116.3M | -$52.3M | -$33.4M | -$34.5M |
| Free cash flow | -$39.4M | -$38.7M | -$48.3M | -$36.2M | -$47.1M | -$39.8M | -$35.5M | -$32.0M | $116.3M | -$52.3M | -$33.4M | -$34.5M |
| Diluted shares | 4.1M | 2.9M | 2.9M | 2.8M | 2.8M | 2.8M | 2.7M | 2.8M | 3.0M | 2.8M | 2.8M | 2.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $41.1M | $41.0M | $37.7M | $8.9M | $26.3M | $29.0M |
| Short-term investments | $15.9M | $58.2M | $99.2M | $171.3M | $186.6M | $228.9M |
| Total debt | $36.1M | $198.8M | $198.5M | $198.3M | $198.0M | $197.8M |
| Total assets | $76.9M | $128.9M | $172.2M | $208.8M | $240.9M | $280.6M |
| Total liabilities | $170.9M | $290.4M | $295.0M | $291.2M | $287.0M | $286.8M |
| Shareholders' equity | -$94.0M | -$161.5M | -$122.8M | -$82.3M | -$46.1M | -$6.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology